United Kingdom: Action for ME (AfME) news

Others have made some really good points already. A few additional ones:

I was heartened to see the "management is supportive" and "pacing & rest" parts. However...

The presentation is not really tailored for its intended audience. The audience for a presentation like this is going to be GPs, AHPs & maybe some physicians who end up being referred a few patients with ME/CFS. This seems aimed at those who have an existing conceptualisation of "myalgic encephalomyelitis" that is congruent with that of the presenters. You're not going to reach the psychosomatic stalwarts, but it may be worth considering in detail where the audience for things like this will be coming from. Some listeners might not be convinced that ME/CFS actually exists as a discrete entity; some may default to psychosomatic explanations but be open to other possibilities; some might just be looking for tips on how to make the consultations that they have less frustrating for them. It would be helpful, I think, for those putting these things together to try to reach listeners where they currently are.

The clinical presentation of ME/CFS looks nothing like what would be expected from an endotheliopathy. At least some of the people they're trying to reach will know this very well. In trying to reduce disbelief, AfME may well end up perpetuating it.

I'm a little worried at the inclusion of neuromuscular symptoms & myoclonic jerks in one of the slides. I'm not sure there's a great deal of evidence for that in ME/CFS and those symptoms may well point to rather different neurological conditions, some of them very serious indeed.

I'm fairly certain that the best approach is to come across as a careful, cautious source of reliable, considered information. Going all-in on some finding from an MDPI journal that's unlikely to replicate, then mixing that up with a helping of BACMEesque goal-setting & pacing-up is unlikely to be beneficial. Being measured & conservative in what you state as fact, openly acknowledging how little is really known, emphasising carefully selected information from sources that are generally thought of as reliable (IOM, NICE) - talking about pragmatic help & support in the absence of known treatments - this, I think, is the best way forward.

If I were able to put a presentation like this together, it would probably be structured something like this:

* What is actually known about ME/CFS: brief history, naming, brief overview of the epidemiology & the emerging genetic picture; why it's not just unexplained chronic fatigue but an illness with discrete symptom patterns & dynamics of its own
* Diagnosis - symptoms, typical cases at different levels of severity, patterns unusual in other conditions (delayed crashes following exertion, new-onset alcohol intolerance, etc); tests & conditions to exclude before making a diagnosis; the little that is known about prognosis (post-viral syndrome/short-term greater likelihood of recovery falling to low recovery rates in long-term patients); how best to communicate the diagnosis to patients, the need for follow-up
* Pragmatic help in the absence of treatment: touching on how this may vary across severities (from help with employers at the mild end through to significant personal care needs at the most severe end); pacing (but not formalised "energy management") & what has no substantive evidence base (CBT & other psychotherapies, exercise programmes, supplements). Give health professionals ideas for things that they can do that will actually help
* Special considerations in rarer & more severe cases: housebound & bedbound patients, severe pain, suicide risk, feeding problems
* Some additional ME/CFS specific context, such as building trust with a patient group who have often experienced significant disbelief & even hostility from the medical profession. Carefully selected quotes from IOM & NG206 to support arguments made

I think 15-20 minutes should be the maximum; the audience may be stretched for time; this may be one of many such presentations they watch. Links to written resources for professionals & patients may be a useful addition at the end.
 
Last edited:
Others have made some really good points already. A few additional ones:

I was heartened to see the "management is supportive" and "pacing & rest" parts. However...

The presentation is not really tailored for its intended audience. The audience for a presentation like this is going to be GPs, AHPs & maybe some physicians who end up being referred a few patients with ME/CFS. This seems aimed at those who have an existing conceptualisation of "myalgic encephalomyelitis" that is congruent with that of the presenters. You're not going to reach the psychosomatic stalwarts, but it may be worth considering in detail where the audience for things like this will be coming from. Some listeners might not be convinced that ME/CFS actually exists as a discrete entity; some may default to psychosomatic explanations but be open to other possibilities; some might just be looking for tips on how to make the consultations that they have less frustrating for them. It would be helpful, I think, for those putting these things together to try to reach listeners where they currently are.

The clinical presentation of ME/CFS looks nothing like what would be expected from an endotheliopathy. At least some of the people they're trying to reach will know this very well. In trying to reduce disbelief, AfME may well end up perpetuating it.

I'm a little worried at the inclusion of neuromuscular symptoms & myoclonic jerks in one of the slides. I'm not sure there's a great deal of evidence for that in ME/CFS and those symptoms may well point to rather different neurological conditions, some of them very serious indeed.

I'm fairly certain that the best approach is to come across as a careful, cautious source of reliable, considered information. Going all-in on some finding from an MDPI journal that's unlikely to replicate, then mixing that up with a helping of BACMEesque goal-setting & pacing-up is unlikely to be beneficial. Being measured & conservative in what you state as fact, openly acknowledging how little is really known, emphasising carefully selected information from sources that are generally thought of as reliable (IOM, NICE) - talking about pragmatic help & support in the absence of known treatments - this, I think, is the best way forward.

If I were able to put a presentation like this together, it would probably be structured something like this:

* What is actually known about ME/CFS: brief history, naming, brief overview of the epidemiology & the emerging genetic picture; why it's not just unexplained chronic fatigue but an illness with discrete symptom patterns & dynamics of its own
* Diagnosis - symptoms, typical cases at different levels of severity, patterns unusual in other conditions (delayed crashes following exertion, new-onset alcohol intolerance, etc); tests & conditions to exclude before making a diagnosis; the little that is known about prognosis (post-viral syndrome/short-term greater likelihood of recovery falling to low recovery rates in long-term patients); how best to communicate the diagnosis to patients, the need for follow-up
* Pragmatic help in the absence of treatment: touching on how this may vary across severities (from help with employers at the mild end through to significant personal care needs at the most severe end); pacing (but not formalised "energy management") & what has no substantive evidence base (CBT & other psychotherapies, exercise programmes, supplements). Give health professionals ideas for things that they can do that will actually help
* Special considerations in rarer & more severe cases: housebound & bedbound patients, severe pain, suicide risk, feeding problems
* Some additional ME/CFS specific context, such as building trust with a patient group who have often experienced significant disbelief & even hostility from the medical profession. Carefully selected quotes from IOM & NG206 to support arguments made

I think 15-20 minutes should be the maximum; the audience may be stretched for time; this may be one of many such presentations they watch. Links to written resources for professionals & patients may be a useful addition at the end.
That sounds very like our Factsheet 3.
Information for Medical Professionals
Maybe we just need to get someone to present that, like Hutan did with the PEM fact sheet.
 
And what is being offered here is better than what most of us face dealing with the NHS
I fully understand the meaning of these comments and that you believe a number of people will feel temporarily reassured that they are no longer seeing the issue of psychology and behaviour in the propositions- without necessarily you share those feelings.

All this jargon represents a more insidious danger of a lack of timely treatment, and I’m sure some others patients will feel the same way –

I do, however, get the impression that the estimate timeframe for a treatment after a GWAS study is a harsh statistical reality that some can't ignore, and prefer not elaborate about. Organisation, searchers, speakers and doctors. To take the step of honestly admitting that this is where we are: at the very beginning of the journey takes courage and it seems they lack of it.
 
Last edited by a moderator:
Both patient charities seem incapable of producing accurate medical advice which doesn’t harm patients, whether through BPS which causes immediate harms or through biobabble which erodes trust with doctors and likely contributes to refusal of care even in life-threatening cases.

This is, bluntly, ridiculous.

What are we going to do about it?

Can either charity be reasoned with?

For what it’s worth, I think the point that many patients want biobabble is absolutely crucial. It’s not a good reason for charities to produce nonsense, but anyone seeking to persuade AfME to change course will need to anticipate that objection and navigate it.

As others have said, S4ME has excellent materials which are underused. Getting them out more widely would be fantastic, but it seems we will be on our own in trying to do that and so many members here are doing more than they can sustain already.
 
For what it’s worth, I think the point that many patients want biobabble is absolutely crucial. It’s not a good reason for charities to produce nonsense, but anyone seeking to persuade AfME to change course will need to anticipate that objection and navigate it.

I think we anticipate it and have done for 5 years. But rather than navigate I suspect we have to meet head on.

Do patients actually want this biobabble? To want biobabble is tantamount to wanting to hold on to unhelpful illness beliefs. The perception that "ME" is all about unhelpful illness beliefs is central to the refusal by physicians to take patients seriously. If charities cannot see the harm it produces they are not the people to advocate.

On the other hand if what patients really want is just an honest indication that somebody has some understanding of their disease AfME are ideally placed to do that by showcasing their DecodeME, epidemiology and other research and its implications. Those implications are extremely positive. They confirm a large body of previous evidence for there being nothing wrong with your connective tissues or mast cells, for no need to say your muscles and brain are running out of oxygen or that your immune system is permanently out of order. They suggest that there is probably a single problem with the unconscious parts of the brain that deal with bodily control and that this is not even associated with any damage or inflammation. They point to a disease a bit like migraine, where revolutionary changes in treatment options have recently occurred.

If there is good positive news out there why oh why continue to hand out unhelpful beliefs?
 
For what it’s worth, I think the point that many patients want biobabble is absolutely crucial. It’s not a good reason for charities to produce nonsense, but anyone seeking to persuade AfME to change course will need to anticipate that objection and navigate it.
Thank you. Understanding the attraction and motivations is key to making a successful argument against these things.
 
I suppose I'm wondering if there's any way of tackling them head on?

No. I have argued against people like Binita Kane and Luis Nacul against off-label prescribing in a working group but the group as a whole was in favour of off-label prescribing. In terms of the biobabble all I can do is to put my opinion in a public space. I have no authority to tackle anyone head on. I am not a practicing ME/CFS physician. I sit on no medical committees. The pressure probably has to come from patient voices.
 
I do, however, get the impression that the estimate timeframe for a treatment after a GWAS study is a harsh statistical reality that some can't ignore, and prefer not elaborate about. Organisation, searchers, speakers and doctors. To take the step of honestly admitting that this is where we are: at the very beginning of the journey takes courage and it seems they lack of it.
I sincerely hope that the journey takes much less time than you outline here, and believe it very possibly will.

I do get the impression that you're right about the beliefs of personel though. That some people in the charities believe this is going to be a very long wait. But if they believe that and are instead giving people a lot of biobabble to stop them despairing (or in the MEAs case teaming up with BACME) that is an infantalising and deeply dishonest practice. Tantamount to the old practice of not telling people they have a terminal illness so that they don't lose hope.

Personally, after I understood that effective treatment based on the emerging research could appear much more quickly than the 15-20 year timeline that was being trotted out everywhere I looked, I leaned much less heavily on biobabble for my hope of finding something that helped and for my understanding of the illness. Perhaps that is what needs to be communicated to get people, especially patients, in our corner.
 
I do, however, get the impression that the estimate timeframe for a treatment after a GWAS study is a harsh statistical reality that some can't ignore, and prefer not elaborate about.

Statistics are not realities, just averages of realities in a world full of bumblers.
If there is a cousin of aripiprazole sitting on the shelf that was no good for depression but has just the right receptor interactions to target ME/CFS there might be a useful drug almost straight away.
;)
 
Back
Top Bottom